Prospective, Multicenter, Randomized Controlled Clinical Study Evaluating the VitaFlow Liberty® Flex Transcatheter Aortic Valve Delivery System for the Treatment of Severe Aortic Stenosis Lesions
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 232 participants.
Also called NCT07145463
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 232 participants
- Sponsor
- First Affiliated Hospital of Fujian Medical University
- First Hospital of China Medical University
- General Hospital of Ningxia Medical University
- Guangdong Provincial People's Hospital
- Renmin Hospital of Wuhan University
- Second Affiliated Hospital of Nanchang University
- Shanghai Zhongshan Hospital
- Sichuan Provincial People's Hospital
- Tang-Du Hospital
- The Affiliated Hospital of Qingdao University
- The First Affiliated Hospital of Nanchang University
- The Second Affiliated Hospital of Dalian Medical University
- Registry
-
NCT07145463
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07145463. Randomized; no masking; primary purpose treatment. Start 2025-07-30 (actual); primary completion 2026-08-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Prospective, Multicenter, Randomized Controlled Clinical Study Evaluating the VitaFlow Liberty® Flex Transcatheter Aortic Valve Delivery System for the Treatment of Severe Aortic Stenosis Lesions
- Acronym
- Flex-TAVR
- Condition
- Aortic Valve Stenosis
- Intervention (Device)
- Transcatheter Aortic Valve Replacement
- Lead sponsor
- Shanghai Zhongshan Hospital
- Collaborator
- First Hospital of China Medical University
- Collaborator
- The Affiliated Hospital of Qingdao University
- Collaborator
- First Affiliated Hospital of Fujian Medical University
- Collaborator
- Renmin Hospital of Wuhan University
- Collaborator
- The First Affiliated Hospital of Nanchang University
- Collaborator
- The Second Affiliated Hospital of Dalian Medical University
- Collaborator
- Guangdong Provincial People's Hospital
- Collaborator
- General Hospital of Ningxia Medical University
- Collaborator
- Sichuan Provincial People's Hospital
- Collaborator
- Second Affiliated Hospital of Nanchang University
- Collaborator
- Tang-Du Hospital
Registry records
Assembled by a program from ROR and ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.
Registry organizations 12
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 10 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 8 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 5 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 26 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 9 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 22 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 31 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 12 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 8 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 8 trials in this atlas.
Record details
- Record id
cardio:ct-nct07145463- Content hash
a5770a37671b6c7caae086f0d8cca1a283c578309a5b97f59db34680f58d3ac9